Blood test can quickly match advanced breast cancer patients to targeted treatments 12 Dec 2019 A blood test can help identify rare mutations in advanced breast cancer, which may enable patients to access effective treatment more quickly in the future, a new clinical trial has found. Find out more Show/Hide
New test predicts chance of living more than a year on targeted breast cancer treatment 08 Dec 2019 A new test could pick out women with advanced breast cancer who are likely to benefit from an exciting new targeted therapy for more than a year. Find out more Show/Hide
ICR responds to NICE approval of palbociclib for treating advanced breast cancer after hormone therapy 28 Nov 2019 The Institute of Cancer Research, London, welcomes the approval by NICE of the innovative targeted cancer treatment palbociclib for women with advanced breast cancer who have already received hormone therapy. Find out more Show/Hide
Personalised ‘liquid biopsy’ could detect return of breast cancer nearly eleven months earlier than hospital scans 01 Aug 2019
ESMO 2018: Major trial shows targeted drug – palbociclib – extends breast cancer survival 20 Oct 2018
ICR responds to NICE approval of new breakthrough drugs on the NHS for women with advanced breast cancer 16 Nov 2017
New blood test detects early resistance to BRCA-targeting drugs for breast and ovarian cancer 02 Nov 2017